🇺🇸 FDA
Patent

US 10501528

Immunoglobulin single variable domain antibody against RSV prefusion F protein

granted A61KA61K2039/505A61K2039/55561

Quick answer

US patent 10501528 (Immunoglobulin single variable domain antibody against RSV prefusion F protein) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Health and Human Services
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K2039/55561, A61K39/12, A61P